Diagnostics News and Research

RSS

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

AirStrip and The Batswadi Group have announced a strategic partnership to bring the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system into ten African countries, with an initial launch in South Africa.

10 Feb 2015

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

A study led by researchers at the Institute for Molecular Medicine Finland FIMM and Faculty of Medicine, University of Helsinki and the Helsinki University Central Hospital Comprehensive Cancer Center, in close collaboration with researchers at Pfizer, has identified a previously unrecognized action of Pfizer's axitinib as a potent inhibitor of the dominant mutation that confers drug resistance to all well tolerated treatments in patients with certain types of leukemia.

10 Feb 2015

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.

From Quest Diagnostics 10 Feb 2015

Biocartis to develop Rapid Ebola Virus Triage Test

Biocartis believes its Rapid Ebola Virus Triage Test could provide a sustainable solution for rapid detection of Ebola-infected patients even after the current Ebola outbreak.

From Biocartis 10 Feb 2015

Roche announces acquisition of Signature Diagnostics

Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.

From Roche Sequencing and Life Science 10 Feb 2015

Xenics and VUmc collaborate in thermography project for clinical research

Xenics, Europe's leading developer and manufacturer of advanced infrared imagers, cameras and customized imaging solutions from the LWIR to the visible realm, is collaborating in path breaking clinical research programs with the VU University Medical Center of Amsterdam, The Netherlands.

9 Feb 2015

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new "Program in Lung Healing," that will further the School's position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system.

9 Feb 2015

Trovagene to sell underwritten public offering of common stock

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The offering is expected to price on or about Friday, February 6, 2015.

6 Feb 2015

Joyce and Don Massey Family Foundation supports U-M’s TBI care and research

A tragic accident 32 years ago forever altered the lives of an entire prominent Michigan auto industry family, as a beloved wife and mother suffered a devastating traumatic brain injury, or TBI.

6 Feb 2015

ECOG-ACRIN Cancer Research Group opens clinical trial for women with newly diagnosed DCIS

In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy.

6 Feb 2015

Global CT market expected to reach $5.1 billion in 2018

The global CT market is expected to grow 5.5 percent to $5.1 billion in 2018, according to a new Kalorama Information report. The combination of product enhancements and the need to cut radiation dose levels is fueling the market. A new federal standard passed into law last year, NEMA Standard XR-29, defining low dose standards and punishing providers not in compliance will help growth, according to the market research publisher.

6 Feb 2015

Half of people in the UK will develop cancer, says new estimate

One in two people will develop cancer in their lifetime, according to new calculations from Cancer Research UK.

5 Feb 2015

Researchers develop smartphone accessory for rapid diagnosis of infectious diseases at point of care

A team of researchers, led by Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has developed a low-cost smartphone accessory that can perform a point-of-care test that simultaneously detects three infectious disease markers from a finger prick of blood in just 15 minutes.

5 Feb 2015

Congressman Fattah meets with Amarantus regarding research efforts for degenerative brain diseases

Congressman Chaka Fattah (D-PA), architect of the Fattah Neuroscience Initiative, met last week with Amarantus, a biotechnology company on their recent efforts to develop treatment and diagnostics for degenerative brain diseases, including Alzheimer's.

4 Feb 2015

Accelerated Cure Project for MS launches nationwide initiative to fuel multiple sclerosis research

The Accelerated Cure Project for Multiple Sclerosis today launches iConquerMS, the nationwide initiative by and for individuals living with multiple sclerosis who recognize the power of their health data and insights and want to harness that power to fuel research.

3 Feb 2015

CellDetect urine test for detecting bladder cancer meets primary endpoint in multi-center clinical study

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that a blinded, multi-center clinical study of the CellDetect non-invasive test for detecting bladder cancer in urine, successfully achieved the study's primary endpoint for effectively detecting the recurrence of bladder cancer in subjects with a history of the disease.

3 Feb 2015

Study identifies correlations between BioLight's TeaRx diagnostic parameters and benchmark tests for dry eye syndrome

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the completion of a U.S. clinical study, conducted by Ora, Inc. Andover, MA, designed to compare widely used benchmark tests for dry eye with its TeaRx diagnostic parameters that test components of tear film.

3 Feb 2015

NQMBC recognizes Cancer Treatment Centers of America for providing quality breast cancer care

Cancer Treatment Centers of America at Midwestern Regional Medical Center has been recognized by the National Quality Measures for Breast Centers Program as being among the top centers in the country for providing quality breast cancer care.

3 Feb 2015

National Centre for Healthcare Photonics to be located in North East of England

One of the most interesting and fastest developing areas in healthcare is the use of light to diagnose and treat medical conditions and illnesses, collectively known as Healthcare Photonics. It includes a range of new phototherapies as well as bio-medical imaging and in vitro diagnostics. The area offers huge potential for the UK and the global healthcare sector. Applications are wide ranging from wound, skin and cancer care to niche applications in neurology and ophthalmology.

2 Feb 2015

NEB announces introduction of one-step cloning and multiple DNA fragment assembly

New England Biolabs announces the introduction of the NEBuilder HiFi DNA Assembly Cloning Kit and Master Mix for one-step cloning and multiple DNA fragment assembly in as little as 15 minutes.

From New England Biolabs 31 Jan 2015

Diagnostics News and Research

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Biocartis to develop Rapid Ebola Virus Triage Test

Roche announces acquisition of Signature Diagnostics

Xenics and VUmc collaborate in thermography project for clinical research

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

Trovagene to sell underwritten public offering of common stock

Joyce and Don Massey Family Foundation supports U-M’s TBI care and research

ECOG-ACRIN Cancer Research Group opens clinical trial for women with newly diagnosed DCIS

Global CT market expected to reach $5.1 billion in 2018

Half of people in the UK will develop cancer, says new estimate

Researchers develop smartphone accessory for rapid diagnosis of infectious diseases at point of care

Congressman Fattah meets with Amarantus regarding research efforts for degenerative brain diseases

Accelerated Cure Project for MS launches nationwide initiative to fuel multiple sclerosis research

CellDetect urine test for detecting bladder cancer meets primary endpoint in multi-center clinical study

Study identifies correlations between BioLight's TeaRx diagnostic parameters and benchmark tests for dry eye syndrome

NQMBC recognizes Cancer Treatment Centers of America for providing quality breast cancer care

National Centre for Healthcare Photonics to be located in North East of England

NEB announces introduction of one-step cloning and multiple DNA fragment assembly

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News